Abstract
The cholesterol-lowering effect of taurine differs based on species, types of hypercholesterolemia, and, in particular, the presence or absence of cholate in an individual’s diet. In this study, the cholesterol-lowering and anti-obesity effects of taurine were tested in rats fed a lard-based, high-fat diet, which was intended to be qualitatively similar to the diets of obese patients, rather than a high cholesterol/sodium diet with cholate intake. Sprague-Dawley (SD) rats were fed either a normal diet, a high-fat (HF) diet, or a taurine (2 %) diet for 12 weeks. After the experimental period, the rats’ organs were harvested and sera were collected to analyze changes in organ weight, histological changes, and serum lipid levels. The HF diet increased body-weight gain (g/day) and weight of epididymal and retroperitoneal fat tissue, while a taurine supplement did not influence weight increased by HF diet. Additionally, histological changes were not detected in the pancreas, liver, or adipose tissue. In contrast, the serum levels of triglycerides, total cholesterol, and LDL-cholesterol levels were significantly increased among rats fed a HF diet, while these levels decreased among rats fed a taurine diet. This result suggests that taurine supplementation is not effective at reducing obesity but it can reduce serum lipid levels that were previously elevated due to a high-fat diet. In conclusion, taurine supplementation may be helpful in ameliorating hyperlipidemia, one of the major risk factors of cardiovascular disease (CVD).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- LDL-C:
-
Low-density lipoprotein cholesterol
- HDL-C:
-
High-density lipoprotein cholesterol
- Tau:
-
Taurine
- CVD:
-
Cardiovascular disease
- HF:
-
High fat
- TC:
-
Total cholesterol
References
Adlercreutz H (1990) Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 201:3–23
Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231
Chen W, Suruga K, Nishimura N, Gouda T, Lam VN, Yokogoshi H (2005) Comparative regulation of major enzymes in the bile acid biosynthesis pathway by cholesterol, cholate and taurine in mice and rats. Life Sci 77:746–757
Chen W, Guo JX, Chang P (2012) The effect of taurine on cholesterol metabolism. Mol Nutr Food Res 56:681–690
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Ito MK (2012) Dyslipidemia: management using optimal lipid-lowering therapy. Ann Pharmacother 46:1368–1381
Kim KS, Oh da H, Kim JY, Lee BG, You JS, Chang KJ, Chung HJ, Yoo MC, Yang HI, Kang JH et al (2012) Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes. Exp Mol Med 44:665–673
Kishida T, Miyazato S, Ogawa H, Ebihara K (2003) Taurine prevents hypercholesterolemia in ovariectomized rats fed corn oil but not in those fed coconut oil. J Nutr 133:2616–2621
Kostis JB (2007) The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease. Cardiovasc Drugs Ther 21:297–309
Levenson JW, Skerrett PJ, Gaziano JM (2002) Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol 5:188–199
Matsushima Y, Sekine T, Kondo Y, Sakurai T, Kameo K, Tachibana M, Murakami S (2003) Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice. Clin Exp Pharmacol Physiol 30:295–299
Mikami N, Hosokawa M, Miyashita K (2012) Dietary combination of fish oil and taurine decreases fat accumulation and ameliorates blood glucose levels in type 2 diabetic/obese KK-A(y) mice. J Food Sci 77:H114–H120
Murakami S, Kondo-Ohta Y, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83–91
Petty MA, Kintz J, DiFrancesco GF (1990) The effects of taurine on atherosclerosis development in cholesterol-fed rabbits. Eur J Pharmacol 180:119–127
Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838S–841S
Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, Hosokawa Y, Ezaki O (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147:3276–3284
Young CE, Karas RH, Kuvin JT (2004) High-density lipoprotein cholesterol and coronary heart disease. Cardiol Rev 12:107–119
Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26:267–271
Acknowledgements
 This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Education, Science and Technology (grant numbers 2010-0024089 and 2011-0009061).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Kim, K.S. et al. (2015). Taurine Ameliorates Hypercholesterolemia But Not Obesity in Rats Fed a Lard-Based, High-Fat Diet. In: Marcinkiewicz, J., Schaffer, S. (eds) Taurine 9. Advances in Experimental Medicine and Biology, vol 803. Springer, Cham. https://doi.org/10.1007/978-3-319-15126-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-15126-7_22
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15125-0
Online ISBN: 978-3-319-15126-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)